6th SSO ASM Lung Track – Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations
Speaker: Prof John Wen-Cheng Chang
Document ID: PC-SG-101262
Listen to Dr John Wen-Cheng CHANG talk about current and next-generation EGFR-TKIs and their efficacy (ORR, PFS) against uncommon EGFR mutations such as Gly719Xaa, Leu861Gln, and Ser768Ile.
Speaker
John Wen-Cheng Chang, MD
Attending Physician, Associate Professor
Division of Hematology-Oncology, Department of Internal Medicine,
Chang Gung Memorial Hospital-Linkou Branch
Taoyuan, Taiwan
6th SSO ASM Lung Track – Evolving Treatment Landscape in EGFRm+ NSCLC
Speaker: Prof John Wen-Cheng Chang
